| abstract |
The present disclosure provides tetrahydro-1H-pyrido[3,4-b]indole compounds or pharmaceutically acceptable salts, for use in modulating diseases mediated by estrogen or other diseases more fully described herein, Solvates, hydrates, prodrugs, stereoisomers, tautomers, rotamers, N-oxides and/or substituted derivatives, or, optionally, in pharmaceutical compositions The tetrahydro-1H-pyrido[3,4-b]indole compound. |